Estée Lauder stock (NYSE: EL) currently trades at $92 per share, around 75% below the level seen in December 2021. In comparison, L'Oréal (OTCMKTS: LRLCY) saw its stock decline 13% over the same period.
French cosmetics company L'Oreal is to acquire a 10% stake in Swiss skin care firm Galderma from a group of major shareholders, the two companies said on Monday.
L'Oreal has announced the acquisition of a 10% stake in dermatology solutions provider Galderma Group , the French cosmetics giant said in a statement on Monday.
L'Oréal S.A. (OTCPK:LRLCF) Q2 2024 Earnings Conference Call July 31, 2024 3:00 AM ET Company Participants Eva Quiroga - Head, IR Nicolas Hieronimus - CEO Christophe Babule - CFO Laurent Schmitt - Global Head, Corporate Finance and Financial Communications Conference Call Participants Iain Simpson - Barclays Celine Pannuti - JPMorgan Bruno Monteyne - Bernstein Guillaume Delmas - UBS Charles Scotti - Kepler Olivier Nicolai - Goldman Sachs Rogerio Fujimori - Stifel Tom Sykes - Deutsche Bank Ashley Wallace - Bank of America Operator Good morning, and welcome to the L'Oréal 2024 Half Year Results Conference Call.
L'Oréal's stock price dropped due to the CEO's comments on the beauty industry and French election results. My valuation analysis shows L'Oréal is fairly valued with strong revenue growth, margins, and diversified portfolio. Despite short-term fluctuations, L'Oréal's stock is a good long-term investment due to its strong fundamentals and growth potential.
Given its attractive valuation, we believe that Estée Lauder stock (NYSE: EL) is currently a better pick over its peer, L'Oréal stock (OTCMKTS: LRLCY). LRLCY stock trades at a higher valuation multiple of 5.7x revenues, versus 2.6x for EL stock.
L'Oréal is a high-quality company in the beauty industry with a track record of rapid earnings growth. The company is operating in an industry with a secular growth trend, has high margins, a solid balance sheet and a management team with significant skin in the game. Despite the relatively low dividend yield of 1.5%, the high, safe and constant dividend growth makes up for it.
At the Viva Technology conference in Paris, L'Oreal showed off demonstrations of "bioprinting," technology that can 3D print humanlike skin, in action. The firm has been using this tech for several years to test new makeups on synthetic skin in its lab rather than animals.